QTI

Allows for Commercial Deployment of the Company's Radiation-Free Breast Imaging Technology Under Distribution Agreement with Gulf Medical Co. QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that its Breast Acoustic CT™ scanner has received official classification and clearance from the Kingdom of Saudi Arabia (KSA) for use as a medical device in that country. The Saudi Food and Drug Authority (SFDA) approval allows QT Imaging's Breast Acoustic CT™ scanner to be marketed, sold, and deployed throughout Saudi Arabia, one

QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, announces that it is expected to be added to the Russell Microcap® Index according to the list of additions posted online May 22, 2026. The addition of QT Imaging to this Index will be finalized at the conclusion of the 2026 Russell indexes reconstitution and, if affirmed, will be effective when the U.S. market opens on June 29, 2026. The June Russell U.S. Indexes reconstitution captures the 4,000 largest U.S. stocks as of April 30, 2026, ranked by total market capitalization. The Russell

8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

QT Imaging Holdings, Inc. ("QT Imaging" or the "Company") (NASDAQ:QTI), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, announced today the closing of its previously announced underwritten public offering of 2,000,000 shares of common stock (or pre-funded warrants in lieu thereof) for gross proceeds of approximately $10 million. Participants in this offering included current investors in QT Imaging as well as new investors. The Company intends to use the net proceeds from the offering for working capital and for general corporate purposes. Ladenburg Thalmann & Co. Inc. acted as sole book-running manager a

424B5 - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

QT Imaging Holdings, Inc. ("QT Imaging" or the "Company") (NASDAQ:QTI), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, announced today the pricing of an underwritten public offering of 2,000,000 shares of common stock (or pre-funded warrants in lieu thereof) for gross proceeds of $10 million. Ladenburg Thalmann & Co. Inc. is acting as sole book-running manager and Northland Capital Markets is acting as co-manager for the offering. "This capital raise marks an important milestone for our company and reflects strong investor confidence in our strategy, execution, and long-term market opportunity," said Dr.

10-Q - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

Revenue of $6.5 Million, Up 133% Year-Over-Year with 13 Scanners Shipped Two Year Extension of the Maturity Date of the Senior Secured Term Loan to March 31, 2029 Secured a Category III CPT Code Specific to QT Imaging, Paving the Way to U.S. Reimbursement Conference Call Begins Today at 4:30 p.m. Eastern Time QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today reported financial results for the three months ended March 31, 2026 and provided a business update. "We continued to execute during the first quarter, making meaningful

QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that Barry Roseman, MD, FACS, is serving as a Senior Medical Advisor to the company. Dr. Roseman's engagement includes clinical implementation of the QT Imaging technology in a busy breast diagnostic and screening center. This installation is expected to support physician training, workflow integration, patient access, and ongoing collection of real-world clinical, operational, financial, patient, and provider experiences. "Dr. Roseman's involvement with QT Imaging is sub

QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that it will report financial results for the three months ended March 31, 2026 after market close on Wednesday, May 13, 2026 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. Date/Time:   Wednesday, May 13, 4:30 p.m. ET / 1:30 p.m. PT       Pre-Registration:   Participants can pre-register for the conference call here:           Callers who pre-register will be

New Viewer, Optimized for QT Imaging's Breast Imaging Technology, Simplifies Correlation of Breast Imaging Across Modalities and Over Time, and Supports Future Integration of AI/ML-Based Tools Product Demonstrations Available at the SBI Breast Imaging Symposium, April 16-19 in Seattle QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced the launch of the QTI Imaging-Olea Viewer, developed in collaboration with Olea Medical, a leader in advanced imaging software solutions. The QT Imaging-Olea Viewer provides a unified plat

EFFECT - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

– New generation reconstruction software improves image quality and performance across challenging breast imaging cases – QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced its latest image reconstruction software update release, version 4.5.0. This next-generation software improves spatial resolution in reflection imaging by implementing optimized, spatially varying deconvolution during reflection image reconstruction, resulting in more accurate image representation while maintaining efficient processing times. Version 4

EFFECT - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

EFFECT - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

EFFECT - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

S-3 - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

POS AM - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

POS AM - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

POS AM - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

10-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

2025 Revenue of $18.9 Million Exceeded Outlook with a Record 40 Scanners Shipped Affirms 2026 Revenue Guidance of $39 Million from Contracted Scanner MOQs and Initial QTI Cloud Platform Revenue Advances Transition to a SaaS- and Biomarker-Driven Medical Imaging Platform Conference Call Begins Today at 4:30 p.m. Eastern Time QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today reported financial results for the three and twelve months ended December 31, 2025 and provided a business update. "I am proud of the transformation QT Im